Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

Por Chen, Jian, Williams, Sandy, Ho, Samantha, Loraine, Howard, Hagan, Deborah, Whaley, Jean M., Feder, John N.
Publicado em 2010

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus

Por Whaley, Jean M, Tirmenstein, Mark, Reilly, Timothy P, Poucher, Simon M, Saye, JoAnne, Parikh, Shamik, List, James F
Publicado em 2012

Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus

Por Reilly, Timothy P., Graziano, Michael J., Janovitz, Evan B., Dorr, Thomas E., Fairchild, Craig, Lee, Francis, Chen, Jian, Wong, Tai, Whaley, Jean M., Tirmenstein, Mark
Publicado em 2014

SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function

Por Jurczak, Michael J., Lee, Hui-Young, Birkenfeld, Andreas L., Jornayvaz, Francois R., Frederick, David W., Pongratz, Rebecca L., Zhao, Xiaoxian, Moeckel, Gilbert W., Samuel, Varman T., Whaley, Jean M., Shulman, Gerald I., Kibbey, Richard G.
Publicado em 2011

Germ-Line Mutations in the von Hippel–Lindau Tumor-Suppressor Gene Are Similar to Somatic von Hippel–Lindau Aberrations in Sporadic Renal Cell Carcinoma

Por Whaley, Jean M., Naglich, Joseph, Gelbert, Lawrence, Hsia, Y. Edward, Lamiell, James M., Green, Jane S., Collins, Debra, Neumann, Hartmut P. H., Laidlaw, Jana, Li, Fred P., Klein-Szanto, Andres J. P., Seizinger, Bernd R., Kley, Nikolai
Publicado em 1994